Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Pediatric and Adolescent Gynecology|March 18, 2022
Infantile/Capillary Hemangioma of the Uterine Corpus: A Rare Cause of Abnormal Genital BleedingConstanza Ralph, Mauricio A Cuello, Paulina M Merino, et al.
Endocrine|May 24, 2014
Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptorMaria Loreto Bravo, Mauricio P Pinto, Ibeth Gonzalez, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|January 16, 2009
Brain natriuretic peptide (BNP) produced by the human chorioamnion may mediate pregnancy myometrial quiescenceJorge A Carvajal, Ana M Delpiano, Mauricio A Cuello, et al.
Gynecologic Oncology|August 7, 2018
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancerMauricio P Pinto, Carlos Balmaceda, Maria L Bravo, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 4, 2008
2-methoxyestradiol mediates apoptosis through caspase-dependent and independent mechanisms in ovarian cancer cells but not in normal counterpartsSumie Kato, Anil Sadarangani, Soledad Lange, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 14, 2021
FIGO staging for carcinoma of the vulva: 2021 revisionAlexander B Olawaiye, Joseph Cotler, Mauricio A Cuello, et al.
Journal of Cellular Physiology|February 24, 2011
Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPISoledad Henriquez, Claudia Calderon, Marisol Quezada, et al.
Hormones & Cancer|July 16, 2011
2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cellsMarisol Quezada, Jorge Diaz, Soledad Henriquez, et al.
Oncotarget|June 9, 2015
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese womenSumie Kato, Lorena Abarzua-Catalan, César Trigo, et al.
Cancers|July 24, 2021
D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor MalignancyJonathan Barra, Javier Cerda-Infante, Lisette Sandoval, et al.
Pageof 4